title: [Probiotics for the treatment of infant colic: a clinical case].
abstract: Infant colic is a prevalent physiological event of healthy children under 3 months of age which can disrupt the child's home environment. Despite its benign natural history, sometimes requires a therapeutic approach. Numerous therapeutical lines have been proposed although its pathogenesis remains unknown and multifactorial. The gut microbiota plays an important role in the infant colic. Several studies have shown less bifidobacteria and lactobacilli in infant colic meanwhile Escherichia, Klebsiella, Serratia, Vibrio, Yersinia and Pseudomonas are more prominent in colon. The probiotic strain L. reuteri DSM 17938, when administered once daily to 10⁸ cfu / day, seems to have the most scientific evidence up to date in the treatment of infant colic, without significant side effects.
authors: Sección Gastroenterología y Nutrición Infantil. Hospital General Universitario Gregorio Marañón Madrid.. jimenapermor@gmail.com.
authors: Jimena
authors: J
authors: Pérez-Moreno
authors: Servicio de Pediatría. Hospital San Rafael, Madrid. España..
authors: Luz
authors: L
authors: Taboada Castro
authors: Sección Gastroenterología y Nutrición Infantil. Hospital General Universitario Gregorio Marañón Madrid..
authors: Mar
authors: M
authors: Tolín Hernani
authors: Sección Gastroenterología y Nutrición Infantil. Hospital General Universitario Gregorio Marañón Madrid..
authors: César
authors: C
authors: Sánchez Sánchez
authors: Sección Gastroenterología y Nutrición Infantil. Hospital General Universitario Gregorio Marañón Madrid..
authors: Guillermo
authors: G
authors: Álvarez-Calatayud
mesh_terms: D003085:Colic / Q000382:microbiology / Q000517:prevention & control*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D064307:Microbiota; D019936:Probiotics / Q000009:adverse effects / Q000627:therapeutic use*